NCT05327075

Brief Summary

it is a cross-sectional study conducted in female patients attending outpatient clinc in our university hospital to assess their awareness regarding the symptoms of premenstrual dysphoric disorders.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 15, 2022

Completed
22 days until next milestone

First Submitted

Initial submission to the registry

April 6, 2022

Completed
8 days until next milestone

First Posted

Study publicly available on registry

April 14, 2022

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2022

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2022

Completed
Last Updated

July 21, 2022

Status Verified

July 1, 2022

Enrollment Period

6 months

First QC Date

April 6, 2022

Last Update Submit

July 19, 2022

Conditions

Premenstrual Dysphoric Disorder

Outcome Measures

Primary Outcomes (1)

  • questionnaire " awareness of participants regarding PMDD symptoms"

    knowledge , attitude and practice through the time of questionnaire

    during the study, an avarege 1 month

Secondary Outcomes (1)

  • questionnaire "impact of the PMDD symptoms on the participants life"

    3 months

Interventions

questionnaireOTHER

it is in the form of questionnaire and scoring tool

Eligibility Criteria

Age18 Years - 45 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility Detailsthe participants in this study including females in reproductive age
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

the study will include females attending gynecological clinics in two hospitals in delta region

You may qualify if:

  • females in reproductive age
  • history of regular menstruation

You may not qualify if:

  • history of any psychological disorders
  • history of chemotherapy in last 6 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Al Azhar University Hospital in Damietta

Damietta, 34511, Egypt

Location

MeSH Terms

Conditions

Premenstrual Dysphoric Disorder

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Premenstrual SyndromeMenstruation DisturbancesPathologic ProcessesPathological Conditions, Signs and SymptomsDepressive DisorderMood DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Target Duration
30 Days
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer in Department of obstetrics and gynecology, Damietta Faculty of Medicine, Al-Azhar University

Study Record Dates

First Submitted

April 6, 2022

First Posted

April 14, 2022

Study Start

March 15, 2022

Primary Completion

September 1, 2022

Study Completion

December 1, 2022

Last Updated

July 21, 2022

Record last verified: 2022-07

Locations

EG(1)